RKDA logo

Arcadia Biosciences (RKDA) Free Cash Flow

Annual FCF

-$15.30 M
-$1.25 M-8.90%

December 31, 2023

Summary

Performance

1-Year Change

-8.9%

3-Year Change

+53%

5-Year Change

-10.22%

15-Year Change

-8.94%

RKDA Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.04%
RKDA annual free cash flow is higher than 13.04% of companies in Consumer Defensive sector

High & Low

All-time High

-$9.85 M

3-Year Low

-$26.88 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RKDA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
RKDA next annual earnings announcement is scheduled for Feb 28, 2025

OtherRKDAcash flowmetrics:

Annual CFO

-$15.29 M
RKDA annual cash flow from operations is -$15.29 million

Annual CFF

$5.51 M
RKDA annual cash flow from financing activities is $5.51 million

Annual CFI

-$4.34 M
RKDA annual cash flow from investing activities is -$4.34 million

Annual CAPEX

$5000.00
RKDA annual capital expenditures is $5000.00

Quarterly FCF

-$1.75 M
+$707.00 K+28.75%

September 30, 2024

Summary

Performance

3-Month Change

+28.75%

1-Year Change

+39.27%

3-Year Change

+49.45%

5-Year Change

+49.45%

RKDA Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.6%
RKDA quarterly free cash flow is higher than 22.6% of companies in Consumer Defensive sector

High & Low

All-time High

-$1.75 M
RKDA quarterly free cash flow is currently at an all-time high

3-Year Low

-$6.75 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RKDA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RKDA next earnings announcement is scheduled for Feb 28, 2025

OtherRKDAcash flowmetrics:

Quarterly CFO

-$1.75 M
RKDA quarterly cash flow from operations is -$1.75 million

Quarterly CFF

$4000.00
RKDA quarterly cash flow from financing activities is $4000.00

Quarterly CFI

$180.00 K
RKDA quarterly cash flow from investing activities is $180.00 thousand

Quarterly CAPEX

$0.00
RKDA quarterly capital expenditures is $0.00

TTM FCF

-$11.58 M
+$1.13 M+8.91%

September 30, 2024

Summary

Performance

3-Month Change

+8.91%

1-Year Change

+14.46%

3-Year Change

+8.03%

5-Year Change

+8.03%

RKDA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.06%
RKDA TTM free cash flow is higher than 11.06% of companies in Consumer Defensive sector

High & Low

All-time High

-$2.13 M

3-Year Low

-$26.88 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RKDA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RKDA next earnings announcement is scheduled for Feb 28, 2025

OtherRKDAcash flowmetrics:

TTM CFO

-$11.56 M
RKDA TTM cash flow from operations is -$11.56 million

TTM CFF

$9000.00
RKDA TTM cash flow from financing activities is $9000.00

TTM CFI

$4.88 M
RKDA TTM cash flow from investing activities is $4.88 million

TTM CAPEX

$16.00 K
RKDA TTM capital expenditures is $16.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$15.30 M
RKDA annual free cash flow is -$15.30 million

Annual CFO

-$15.29 M
RKDA annual cash flow from operations is -$15.29 million

Annual CAPEX

$5000.00
RKDA annual capital expenditures is $5000.00

RKDA Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.9%+39.3%+14.5%
3 y3 years+53.0%+49.5%+8.0%
5 y5 years-10.2%+49.5%+8.0%

RKDA Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.9%+43.1%at high+74.0%at high+56.9%
5 y5-year-8.9%+53.0%at high+82.6%at high+64.4%
alltimeall time-55.4%+53.0%at high+82.6%-444.6%+64.4%

Arcadia Biosciences Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.75 M(-28.8%)
-$11.58 M(-8.9%)
Jun 2024
-
-$2.46 M(-23.7%)
-$12.71 M(-15.6%)
Mar 2024
-
-$3.22 M(-22.2%)
-$15.06 M(-1.6%)
Dec 2023
-$15.30 M(+8.9%)
-$4.14 M(+43.7%)
-$15.30 M(+13.0%)
Sep 2023
-
-$2.88 M(-39.9%)
-$13.54 M(-3.5%)
Jun 2023
-
-$4.80 M(+38.6%)
-$14.02 M(+11.4%)
Mar 2023
-
-$3.47 M(+45.5%)
-$12.59 M(-10.4%)
Dec 2022
-$14.05 M(-47.7%)
-$2.38 M(-29.3%)
-$14.05 M(-23.7%)
Sep 2022
-
-$3.37 M(0.0%)
-$18.41 M(-21.7%)
Jun 2022
-
-$3.37 M(-31.6%)
-$23.52 M(-11.6%)
Mar 2022
-
-$4.92 M(-27.0%)
-$26.61 M(-1.0%)
Dec 2021
-$26.88 M(-17.4%)
-$6.75 M(-20.4%)
-$26.88 M(-1.1%)
Sep 2021
-
-$8.47 M(+31.2%)
-$27.18 M(+4.9%)
Jun 2021
-
-$6.46 M(+24.4%)
-$25.91 M(-6.5%)
Mar 2021
-
-$5.19 M(-26.3%)
-$27.70 M(-14.9%)
Dec 2020
-$32.55 M(+74.3%)
-$7.05 M(-2.2%)
-$32.55 M(+4.6%)
Sep 2020
-
-$7.21 M(-12.6%)
-$31.12 M(+10.2%)
Jun 2020
-
-$8.25 M(-17.9%)
-$28.23 M(+14.4%)
Mar 2020
-
-$10.05 M(+79.1%)
-$24.67 M(+32.1%)
Dec 2019
-$18.68 M
-$5.61 M(+29.9%)
-$18.68 M(+17.3%)
Sep 2019
-
-$4.32 M(-7.8%)
-$15.92 M(+1.8%)
Jun 2019
-
-$4.69 M(+15.5%)
-$15.64 M(+2.3%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$4.06 M(+42.1%)
-$15.29 M(+10.1%)
Dec 2018
-$13.88 M(-1.2%)
-$2.86 M(-29.3%)
-$13.88 M(+1.2%)
Sep 2018
-
-$4.04 M(-6.8%)
-$13.71 M(+13.7%)
Jun 2018
-
-$4.34 M(+63.6%)
-$12.05 M(-0.4%)
Mar 2018
-
-$2.65 M(-1.3%)
-$12.11 M(-13.8%)
Dec 2017
-$14.04 M(-18.8%)
-$2.69 M(+12.6%)
-$14.04 M(-10.2%)
Sep 2017
-
-$2.38 M(-45.7%)
-$15.64 M(-9.1%)
Jun 2017
-
-$4.39 M(-4.3%)
-$17.22 M(+2.0%)
Mar 2017
-
-$4.59 M(+7.0%)
-$16.88 M(-2.3%)
Dec 2016
-$17.29 M(+13.3%)
-$4.29 M(+8.4%)
-$17.29 M(+1.6%)
Sep 2016
-
-$3.96 M(-2.4%)
-$17.02 M(-3.9%)
Jun 2016
-
-$4.05 M(-18.8%)
-$17.70 M(+0.3%)
Mar 2016
-
-$4.99 M(+24.3%)
-$17.65 M(+15.6%)
Dec 2015
-$15.26 M(+2.2%)
-$4.02 M(-13.4%)
-$15.26 M(+8.9%)
Sep 2015
-
-$4.64 M(+16.0%)
-$14.01 M(+6.8%)
Jun 2015
-
-$4.00 M(+53.6%)
-$13.11 M(-14.9%)
Mar 2015
-
-$2.60 M(-5.8%)
-$15.41 M(+3.2%)
Dec 2014
-$14.94 M(+51.7%)
-$2.77 M(-26.1%)
-$14.94 M(+22.7%)
Sep 2014
-
-$3.74 M(-40.6%)
-$12.17 M(+44.4%)
Jun 2014
-
-$6.30 M(+196.4%)
-$8.43 M(+296.4%)
Mar 2014
-
-$2.13 M
-$2.13 M
Dec 2013
-$9.85 M(-0.3%)
-
-
Dec 2012
-$9.87 M
-
-

FAQ

  • What is Arcadia Biosciences annual free cash flow?
  • What is the all time high annual FCF for Arcadia Biosciences?
  • What is Arcadia Biosciences annual FCF year-on-year change?
  • What is Arcadia Biosciences quarterly free cash flow?
  • What is the all time high quarterly FCF for Arcadia Biosciences?
  • What is Arcadia Biosciences quarterly FCF year-on-year change?
  • What is Arcadia Biosciences TTM free cash flow?
  • What is the all time high TTM FCF for Arcadia Biosciences?
  • What is Arcadia Biosciences TTM FCF year-on-year change?

What is Arcadia Biosciences annual free cash flow?

The current annual FCF of RKDA is -$15.30 M

What is the all time high annual FCF for Arcadia Biosciences?

Arcadia Biosciences all-time high annual free cash flow is -$9.85 M

What is Arcadia Biosciences annual FCF year-on-year change?

Over the past year, RKDA annual free cash flow has changed by -$1.25 M (-8.90%)

What is Arcadia Biosciences quarterly free cash flow?

The current quarterly FCF of RKDA is -$1.75 M

What is the all time high quarterly FCF for Arcadia Biosciences?

Arcadia Biosciences all-time high quarterly free cash flow is -$1.75 M

What is Arcadia Biosciences quarterly FCF year-on-year change?

Over the past year, RKDA quarterly free cash flow has changed by +$1.13 M (+39.27%)

What is Arcadia Biosciences TTM free cash flow?

The current TTM FCF of RKDA is -$11.58 M

What is the all time high TTM FCF for Arcadia Biosciences?

Arcadia Biosciences all-time high TTM free cash flow is -$2.13 M

What is Arcadia Biosciences TTM FCF year-on-year change?

Over the past year, RKDA TTM free cash flow has changed by +$1.96 M (+14.46%)